awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26824310-5B5CC64D-B680-4BF8-8EB5-649E1050B0F9
Q26824310-5B5CC64D-B680-4BF8-8EB5-649E1050B0F9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26824310-5B5CC64D-B680-4BF8-8EB5-649E1050B0F9
Ipilimumab, vemurafenib, dabrafenib, and trametinib: synergistic competitors in the clinical management of BRAF mutant malignant melanoma
P2860
Q26824310-5B5CC64D-B680-4BF8-8EB5-649E1050B0F9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26824310-5B5CC64D-B680-4BF8-8EB5-649E1050B0F9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f063966b7f3043d11e45825c8715cacff025d62d
P2860
The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner